| Dr Bruce A Brown, MD | |
|
200 Ucla Medical Plz, Ste 140, Los Angeles, CA 90095-3075 | |
| (310) 319-4418 | |
| Not Available |
| Full Name | Dr Bruce A Brown |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 200 Ucla Medical Plz, Los Angeles, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033147202 | NPI | - | NPPES |
| 00G412530 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | G41253 (California) | Primary |
| Entity Name | County Of Los Angeles |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851363188 PECOS PAC ID: 1850296534 Enrollment ID: O20031204001218 |
News Archive
A study led by Karolinska Institutet in Sweden reports for the first time the positive effects of an active vaccine against Alzheimer's disease. The new vaccine, CAD106, can prove a breakthrough in the search for a cure for this seriously debilitating dementia disease. The study is published in the distinguished scientific journal Lancet Neurology.
Scientists are reporting that particle size affects the toxicity of zinc oxide, a material widely used in sunscreens. Particles smaller than 100 nanometers are slightly more toxic to colon cells than conventional zinc oxide. Solid zinc oxide was more toxic than equivalent amounts of soluble zinc, and direct particle to cell contact was required to cause cell death. Their study is in ACS' Chemical Research in Toxicology, a monthly journal.
Image Solutions Inc. (ISI), a leading provider of electronic submissions management and publishing solutions for the life sciences industry, has unveiled a prestigious line-up of speakers for its annual eSolutions Conference in Barcelona, Spain, this September to support an agenda aimed at reinventing the regulatory function.
A collaborative primary care program aimed at enhancing provision for chronic diseases, patient self-management, access, and Aboriginal healthcare has shown improvement across the vast majority of measures, Australian study findings indicate.
Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bruce A Brown, MD 5767 W Century Blvd, Ste 400, Los Angeles, CA 90045-5631 Ph: (310) 319-4418 | Dr Bruce A Brown, MD 200 Ucla Medical Plz, Ste 140, Los Angeles, CA 90095-3075 Ph: (310) 319-4418 |
News Archive
A study led by Karolinska Institutet in Sweden reports for the first time the positive effects of an active vaccine against Alzheimer's disease. The new vaccine, CAD106, can prove a breakthrough in the search for a cure for this seriously debilitating dementia disease. The study is published in the distinguished scientific journal Lancet Neurology.
Scientists are reporting that particle size affects the toxicity of zinc oxide, a material widely used in sunscreens. Particles smaller than 100 nanometers are slightly more toxic to colon cells than conventional zinc oxide. Solid zinc oxide was more toxic than equivalent amounts of soluble zinc, and direct particle to cell contact was required to cause cell death. Their study is in ACS' Chemical Research in Toxicology, a monthly journal.
Image Solutions Inc. (ISI), a leading provider of electronic submissions management and publishing solutions for the life sciences industry, has unveiled a prestigious line-up of speakers for its annual eSolutions Conference in Barcelona, Spain, this September to support an agenda aimed at reinventing the regulatory function.
A collaborative primary care program aimed at enhancing provision for chronic diseases, patient self-management, access, and Aboriginal healthcare has shown improvement across the vast majority of measures, Australian study findings indicate.
Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).
› Verified 4 days ago
Dr. Lucille Chaille, Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 N State St, Los Angeles, CA 90033 Phone: 323-226-2170 Fax: 323-226-5760 | |
Erin Meisel, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1200 N State St, Gnh 3900, Los Angeles, CA 90033 Phone: 323-226-7210 | |
Micah Paul Adamson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Ucla Medical Plz Ste 755, Los Angeles, CA 90024 Phone: 310-319-1234 | |
Dr. Steven Lawrence Zeitzew, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 8113 1/2 Melrose Ave, Los Angeles, CA 90046 Phone: 323-852-1259 Fax: 323-852-1259 | |
Dr. William T Long, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1300 N Vermont Ave Ste 100, Los Angeles, CA 90027 Phone: 323-913-4300 | |
Kathleen Rose Savage, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 E Cesar E Chavez Ave, Suite 2200, Los Angeles, CA 90033 Phone: 323-264-7600 Fax: 323-261-8027 | |
Dr. Tracey Crothers Didinger, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 N. State Street, Gnh 3900, Los Angeles, CA 90033 Phone: 323-226-7346 |